Loss of lineage antigens is a common feature of apoptotic lymphocytes

The analysis of apoptosis in cell populations involves the detection of their specific lineage antigen (LAg) expression. This experimental approach relies on their assumed constant expression, but it is unclear whether such expression is actually maintained during cell death. We examined whether the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of leukocyte biology 2004-09, Vol.76 (3), p.609-615
Hauptverfasser: Diaz, D, Prieto, A, Barcenilla, H, Monserrat, J, Prieto, P, Sánchez, M A, Reyes, E, Hernandez-Fuentes, M P, de la Hera, A, Orfao, A, Alvarez-Mon, M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 615
container_issue 3
container_start_page 609
container_title Journal of leukocyte biology
container_volume 76
creator Diaz, D
Prieto, A
Barcenilla, H
Monserrat, J
Prieto, P
Sánchez, M A
Reyes, E
Hernandez-Fuentes, M P
de la Hera, A
Orfao, A
Alvarez-Mon, M
description The analysis of apoptosis in cell populations involves the detection of their specific lineage antigen (LAg) expression. This experimental approach relies on their assumed constant expression, but it is unclear whether such expression is actually maintained during cell death. We examined whether the loss of LAgs is a common feature of apoptotic lymphocytes and whether some might completely lose their LAgs. The changes in the expression of CD3, CD5, CD8, CD4, CD28, CD56, and CD19 were monitored in highly purified lymphocyte populations obtained by negative selection in a fluorescence‐activated cell sorter. These were cultured for 24 h with or without phytohemagglutinin or staurosporin. For each LAg‐positive subset studied, apoptosis was consistently more common among cells showing partial or total loss of LAg expression compared with cells maintaining their initial LAg levels. The kinetics of expression loss was rapid for CD8, CD56, and CD28, and more than 80% of initial expression was lost in the early stages of apoptosis but was slower for CD3, CD5, and CD4. For CD3 and CD5, expression was dependent on the apoptotic stimulus used. It is interesting that loss of antigen expression was independent of cell size. This phenomenon was also found in nonmanipulated, highly pure CD19 B lymphocytes of peripheral blood mononuclear cells from B chronic lymphocytic leukemia patients. Loss of LAg expression appeared to be a common feature of apoptotic lymphocytes under all the conditions assayed. The different kinetic patterns of LAg loss suggest apoptotic cells might actively regulate this process.
doi_str_mv 10.1189/jlb.0304171
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66819346</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>66819346</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3879-12422500ed2b899d5882338e2663f8bca4b9ef8a4e394b07bdcbc82f520fcd783</originalsourceid><addsrcrecordid>eNqFkD1PwzAQQC0EgvIxsaMssKDA2U5sZwTEpyqxwGw5zqU1cuIQp4r670nVSmww3fLune4Rck7hhlJV3H758gY4ZFTSPTKjBVcpF5LvkxnIjKZ5BnBEjmP8AgDOBBySI5pTqSTQGXmchxiTUCfetWgWmJh2cAtsY-JiYhIbmia0SY1mWPW44UwXuiEMziZ-3XTLYNcDxlNyUBsf8Ww3T8jn0-PHw0s6f39-fbibp5YrWaSUZYzlAFixUhVFlSvFOFfIhOC1Kq3JygJrZTLkRVaCLCtbWsXqnEFtK6n4Cbnaers-fK8wDrpx0aL3psWwiloINf2fiX9BKiXPmdgYr7eg7acQPda6611j-rWmoDd59ZRX7_JO9MVOuyobrH7ZXc8JgC0wOo_rv1z6bX4PAopp5XK7snSL5eh61LEx3k8XmB7HUQrN9Yb7AYVqkM4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17735268</pqid></control><display><type>article</type><title>Loss of lineage antigens is a common feature of apoptotic lymphocytes</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Diaz, D ; Prieto, A ; Barcenilla, H ; Monserrat, J ; Prieto, P ; Sánchez, M A ; Reyes, E ; Hernandez-Fuentes, M P ; de la Hera, A ; Orfao, A ; Alvarez-Mon, M</creator><creatorcontrib>Diaz, D ; Prieto, A ; Barcenilla, H ; Monserrat, J ; Prieto, P ; Sánchez, M A ; Reyes, E ; Hernandez-Fuentes, M P ; de la Hera, A ; Orfao, A ; Alvarez-Mon, M</creatorcontrib><description>The analysis of apoptosis in cell populations involves the detection of their specific lineage antigen (LAg) expression. This experimental approach relies on their assumed constant expression, but it is unclear whether such expression is actually maintained during cell death. We examined whether the loss of LAgs is a common feature of apoptotic lymphocytes and whether some might completely lose their LAgs. The changes in the expression of CD3, CD5, CD8, CD4, CD28, CD56, and CD19 were monitored in highly purified lymphocyte populations obtained by negative selection in a fluorescence‐activated cell sorter. These were cultured for 24 h with or without phytohemagglutinin or staurosporin. For each LAg‐positive subset studied, apoptosis was consistently more common among cells showing partial or total loss of LAg expression compared with cells maintaining their initial LAg levels. The kinetics of expression loss was rapid for CD8, CD56, and CD28, and more than 80% of initial expression was lost in the early stages of apoptosis but was slower for CD3, CD5, and CD4. For CD3 and CD5, expression was dependent on the apoptotic stimulus used. It is interesting that loss of antigen expression was independent of cell size. This phenomenon was also found in nonmanipulated, highly pure CD19 B lymphocytes of peripheral blood mononuclear cells from B chronic lymphocytic leukemia patients. Loss of LAg expression appeared to be a common feature of apoptotic lymphocytes under all the conditions assayed. The different kinetic patterns of LAg loss suggest apoptotic cells might actively regulate this process.</description><identifier>ISSN: 0741-5400</identifier><identifier>EISSN: 1938-3673</identifier><identifier>DOI: 10.1189/jlb.0304171</identifier><identifier>PMID: 15178701</identifier><language>eng</language><publisher>United States: Society for Leukocyte Biology</publisher><subject>7‐amino actinomycin D ; annexin V ; Antigens, CD - immunology ; Antigens, CD - metabolism ; Apoptosis - immunology ; Cell Lineage - immunology ; FACS ; Flow Cytometry ; Humans ; Kinetics ; Leukemia, B-Cell - immunology ; loss ; Lymphocytes - immunology ; Lymphocytes - metabolism ; physiological ; Phytohemagglutinins - pharmacology ; Staurosporine - pharmacology</subject><ispartof>Journal of leukocyte biology, 2004-09, Vol.76 (3), p.609-615</ispartof><rights>2004 Society for Leukocyte Biology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3879-12422500ed2b899d5882338e2663f8bca4b9ef8a4e394b07bdcbc82f520fcd783</citedby><cites>FETCH-LOGICAL-c3879-12422500ed2b899d5882338e2663f8bca4b9ef8a4e394b07bdcbc82f520fcd783</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1189%2Fjlb.0304171$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1189%2Fjlb.0304171$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15178701$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Diaz, D</creatorcontrib><creatorcontrib>Prieto, A</creatorcontrib><creatorcontrib>Barcenilla, H</creatorcontrib><creatorcontrib>Monserrat, J</creatorcontrib><creatorcontrib>Prieto, P</creatorcontrib><creatorcontrib>Sánchez, M A</creatorcontrib><creatorcontrib>Reyes, E</creatorcontrib><creatorcontrib>Hernandez-Fuentes, M P</creatorcontrib><creatorcontrib>de la Hera, A</creatorcontrib><creatorcontrib>Orfao, A</creatorcontrib><creatorcontrib>Alvarez-Mon, M</creatorcontrib><title>Loss of lineage antigens is a common feature of apoptotic lymphocytes</title><title>Journal of leukocyte biology</title><addtitle>J Leukoc Biol</addtitle><description>The analysis of apoptosis in cell populations involves the detection of their specific lineage antigen (LAg) expression. This experimental approach relies on their assumed constant expression, but it is unclear whether such expression is actually maintained during cell death. We examined whether the loss of LAgs is a common feature of apoptotic lymphocytes and whether some might completely lose their LAgs. The changes in the expression of CD3, CD5, CD8, CD4, CD28, CD56, and CD19 were monitored in highly purified lymphocyte populations obtained by negative selection in a fluorescence‐activated cell sorter. These were cultured for 24 h with or without phytohemagglutinin or staurosporin. For each LAg‐positive subset studied, apoptosis was consistently more common among cells showing partial or total loss of LAg expression compared with cells maintaining their initial LAg levels. The kinetics of expression loss was rapid for CD8, CD56, and CD28, and more than 80% of initial expression was lost in the early stages of apoptosis but was slower for CD3, CD5, and CD4. For CD3 and CD5, expression was dependent on the apoptotic stimulus used. It is interesting that loss of antigen expression was independent of cell size. This phenomenon was also found in nonmanipulated, highly pure CD19 B lymphocytes of peripheral blood mononuclear cells from B chronic lymphocytic leukemia patients. Loss of LAg expression appeared to be a common feature of apoptotic lymphocytes under all the conditions assayed. The different kinetic patterns of LAg loss suggest apoptotic cells might actively regulate this process.</description><subject>7‐amino actinomycin D</subject><subject>annexin V</subject><subject>Antigens, CD - immunology</subject><subject>Antigens, CD - metabolism</subject><subject>Apoptosis - immunology</subject><subject>Cell Lineage - immunology</subject><subject>FACS</subject><subject>Flow Cytometry</subject><subject>Humans</subject><subject>Kinetics</subject><subject>Leukemia, B-Cell - immunology</subject><subject>loss</subject><subject>Lymphocytes - immunology</subject><subject>Lymphocytes - metabolism</subject><subject>physiological</subject><subject>Phytohemagglutinins - pharmacology</subject><subject>Staurosporine - pharmacology</subject><issn>0741-5400</issn><issn>1938-3673</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkD1PwzAQQC0EgvIxsaMssKDA2U5sZwTEpyqxwGw5zqU1cuIQp4r670nVSmww3fLune4Rck7hhlJV3H758gY4ZFTSPTKjBVcpF5LvkxnIjKZ5BnBEjmP8AgDOBBySI5pTqSTQGXmchxiTUCfetWgWmJh2cAtsY-JiYhIbmia0SY1mWPW44UwXuiEMziZ-3XTLYNcDxlNyUBsf8Ww3T8jn0-PHw0s6f39-fbibp5YrWaSUZYzlAFixUhVFlSvFOFfIhOC1Kq3JygJrZTLkRVaCLCtbWsXqnEFtK6n4Cbnaers-fK8wDrpx0aL3psWwiloINf2fiX9BKiXPmdgYr7eg7acQPda6611j-rWmoDd59ZRX7_JO9MVOuyobrH7ZXc8JgC0wOo_rv1z6bX4PAopp5XK7snSL5eh61LEx3k8XmB7HUQrN9Yb7AYVqkM4</recordid><startdate>200409</startdate><enddate>200409</enddate><creator>Diaz, D</creator><creator>Prieto, A</creator><creator>Barcenilla, H</creator><creator>Monserrat, J</creator><creator>Prieto, P</creator><creator>Sánchez, M A</creator><creator>Reyes, E</creator><creator>Hernandez-Fuentes, M P</creator><creator>de la Hera, A</creator><creator>Orfao, A</creator><creator>Alvarez-Mon, M</creator><general>Society for Leukocyte Biology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>200409</creationdate><title>Loss of lineage antigens is a common feature of apoptotic lymphocytes</title><author>Diaz, D ; Prieto, A ; Barcenilla, H ; Monserrat, J ; Prieto, P ; Sánchez, M A ; Reyes, E ; Hernandez-Fuentes, M P ; de la Hera, A ; Orfao, A ; Alvarez-Mon, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3879-12422500ed2b899d5882338e2663f8bca4b9ef8a4e394b07bdcbc82f520fcd783</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>7‐amino actinomycin D</topic><topic>annexin V</topic><topic>Antigens, CD - immunology</topic><topic>Antigens, CD - metabolism</topic><topic>Apoptosis - immunology</topic><topic>Cell Lineage - immunology</topic><topic>FACS</topic><topic>Flow Cytometry</topic><topic>Humans</topic><topic>Kinetics</topic><topic>Leukemia, B-Cell - immunology</topic><topic>loss</topic><topic>Lymphocytes - immunology</topic><topic>Lymphocytes - metabolism</topic><topic>physiological</topic><topic>Phytohemagglutinins - pharmacology</topic><topic>Staurosporine - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Diaz, D</creatorcontrib><creatorcontrib>Prieto, A</creatorcontrib><creatorcontrib>Barcenilla, H</creatorcontrib><creatorcontrib>Monserrat, J</creatorcontrib><creatorcontrib>Prieto, P</creatorcontrib><creatorcontrib>Sánchez, M A</creatorcontrib><creatorcontrib>Reyes, E</creatorcontrib><creatorcontrib>Hernandez-Fuentes, M P</creatorcontrib><creatorcontrib>de la Hera, A</creatorcontrib><creatorcontrib>Orfao, A</creatorcontrib><creatorcontrib>Alvarez-Mon, M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of leukocyte biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Diaz, D</au><au>Prieto, A</au><au>Barcenilla, H</au><au>Monserrat, J</au><au>Prieto, P</au><au>Sánchez, M A</au><au>Reyes, E</au><au>Hernandez-Fuentes, M P</au><au>de la Hera, A</au><au>Orfao, A</au><au>Alvarez-Mon, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Loss of lineage antigens is a common feature of apoptotic lymphocytes</atitle><jtitle>Journal of leukocyte biology</jtitle><addtitle>J Leukoc Biol</addtitle><date>2004-09</date><risdate>2004</risdate><volume>76</volume><issue>3</issue><spage>609</spage><epage>615</epage><pages>609-615</pages><issn>0741-5400</issn><eissn>1938-3673</eissn><abstract>The analysis of apoptosis in cell populations involves the detection of their specific lineage antigen (LAg) expression. This experimental approach relies on their assumed constant expression, but it is unclear whether such expression is actually maintained during cell death. We examined whether the loss of LAgs is a common feature of apoptotic lymphocytes and whether some might completely lose their LAgs. The changes in the expression of CD3, CD5, CD8, CD4, CD28, CD56, and CD19 were monitored in highly purified lymphocyte populations obtained by negative selection in a fluorescence‐activated cell sorter. These were cultured for 24 h with or without phytohemagglutinin or staurosporin. For each LAg‐positive subset studied, apoptosis was consistently more common among cells showing partial or total loss of LAg expression compared with cells maintaining their initial LAg levels. The kinetics of expression loss was rapid for CD8, CD56, and CD28, and more than 80% of initial expression was lost in the early stages of apoptosis but was slower for CD3, CD5, and CD4. For CD3 and CD5, expression was dependent on the apoptotic stimulus used. It is interesting that loss of antigen expression was independent of cell size. This phenomenon was also found in nonmanipulated, highly pure CD19 B lymphocytes of peripheral blood mononuclear cells from B chronic lymphocytic leukemia patients. Loss of LAg expression appeared to be a common feature of apoptotic lymphocytes under all the conditions assayed. The different kinetic patterns of LAg loss suggest apoptotic cells might actively regulate this process.</abstract><cop>United States</cop><pub>Society for Leukocyte Biology</pub><pmid>15178701</pmid><doi>10.1189/jlb.0304171</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0741-5400
ispartof Journal of leukocyte biology, 2004-09, Vol.76 (3), p.609-615
issn 0741-5400
1938-3673
language eng
recordid cdi_proquest_miscellaneous_66819346
source Oxford University Press Journals All Titles (1996-Current); MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects 7‐amino actinomycin D
annexin V
Antigens, CD - immunology
Antigens, CD - metabolism
Apoptosis - immunology
Cell Lineage - immunology
FACS
Flow Cytometry
Humans
Kinetics
Leukemia, B-Cell - immunology
loss
Lymphocytes - immunology
Lymphocytes - metabolism
physiological
Phytohemagglutinins - pharmacology
Staurosporine - pharmacology
title Loss of lineage antigens is a common feature of apoptotic lymphocytes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-20T06%3A34%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Loss%20of%20lineage%20antigens%20is%20a%20common%20feature%20of%20apoptotic%20lymphocytes&rft.jtitle=Journal%20of%20leukocyte%20biology&rft.au=Diaz,%20D&rft.date=2004-09&rft.volume=76&rft.issue=3&rft.spage=609&rft.epage=615&rft.pages=609-615&rft.issn=0741-5400&rft.eissn=1938-3673&rft_id=info:doi/10.1189/jlb.0304171&rft_dat=%3Cproquest_cross%3E66819346%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17735268&rft_id=info:pmid/15178701&rfr_iscdi=true